Dr. Minagar is a Professor of Neurology at LSU Health Sciences Center in Shreveport, Louisiana. He’s a certified Physician Investigator by Association of Clinical Research Professionals, member of the editorial board of Future Neurology, Neurological Research, and Alzheimer’s Disease Research Board. Dr. Minagar is the author of 231 journal articles and 33 book chapters, and editor of 10 books.

• 1. Multiple Sclerosis: clinical Features, Pathophysiology, Diagnosis, and Management2. Neuttralizing Antibodies and Multiple Sclerosis inthe Era of Disease Modifying Treatments3. Animal Models of Multiple Sclerosis4. Neuroimaging of Multiple Sclerosis and Other Immune-Mediated Diseases of Central Nervous System: An Update5. Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis6. Acute Transverse Myelitis: Clinical Features, Pathophysiology, and Treatment Options7. Remyelination in Multiple Sclerosis: A Mechanistic Look8. The Way Forward With Vitamin D in Multiple Sclerosis9. Autoimmune Encephalitis: Clinical Features, Pathophysiology, and Management10. Immune Dysregulation in Epilepsy11. Neurosarcoidosis: Clinical Features, Pathophysiology, and Management12. Existing and Emerging Therapies for Multiple Sclerosis13. Tumefactive Demyelination in Multiple Sclerosis: Clinical Presentation, Pathophysiology and Treatment Options14. Pediatric Multiple Sclerosis15. Acute Disseminated Encephalomyelitis: Clinical Presentation, Pathophysiology, Diagnosis, and Treatment16. Neuromyelitis Optica Spectrum Disorders17. Optic Neuritis: Clinical Manifestations, Pathophysiology, and Management18. Ischemic Demyelination19. Inflammatory Mechanisms in Ischemic Cerebrovascular Disease20. Two-Pore Domain Potassium Channels (K2Ps) as Drug Targets in Neuroinflammation21. Interferon Gamma Versus Beta-Interferon in Pathogenesis of Multiple Sclerosis: Battle of Two Interferons22. Inflammatory Mediators in Obstructive Sleep Apnea23. Central Nervous System Vasculitis24. Role of Inflammatory Mechanisms in Guillain-Barre’ Syndrome25. Roles of Macrophages and Astrocytes in Pathogenesis of Multiple Sclerosis26. Blood-Brain Barrier Disruption During Neuroinflammation 27. Roles of Toll-Like Receptors in Pathophysiology of Alzheimer’s Disease and Multiple Sclerosis28. Role of Neuroinflammation in the Pathophysiology of Traumatic Brain Injury29. The Contribution of Extra Cranial Venous Drainage to Neuro-Inflammation in Multiple Sclerosis30. Lymphatic Drainage of the CNS and Its Role in Neuroinflammation and Neurodegenerative Disease31. A Complete Review on Epigenetic Biomarkers in MS

Dr. Minagar is a Professor of Neurology at LSU Health Sciences Center in Shreveport, Louisiana. He’s a certified Physician Investigator by Association of Clinical Research Professionals, member of the editorial board of Future Neurology, Neurological Research, and Alzheimer’s Disease Research Board. Dr. Minagar is the author of 231 journal articles and 33 book chapters, and editor of 10 books.

• 1. Multiple Sclerosis: clinical Features, Pathophysiology, Diagnosis, and Management2. Neuttralizing Antibodies and Multiple Sclerosis inthe Era of Disease Modifying Treatments3. Animal Models of Multiple Sclerosis4. Neuroimaging of Multiple Sclerosis and Other Immune-Mediated Diseases of Central Nervous System: An Update5. Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis6. Acute Transverse Myelitis: Clinical Features, Pathophysiology, and Treatment Options7. Remyelination in Multiple Sclerosis: A Mechanistic Look8. The Way Forward With Vitamin D in Multiple Sclerosis9. Autoimmune Encephalitis: Clinical Features, Pathophysiology, and Management10. Immune Dysregulation in Epilepsy11. Neurosarcoidosis: Clinical Features, Pathophysiology, and Management12. Existing and Emerging Therapies for Multiple Sclerosis13. Tumefactive Demyelination in Multiple Sclerosis: Clinical Presentation, Pathophysiology and Treatment Options14. Pediatric Multiple Sclerosis15. Acute Disseminated Encephalomyelitis: Clinical Presentation, Pathophysiology, Diagnosis, and Treatment16. Neuromyelitis Optica Spectrum Disorders17. Optic Neuritis: Clinical Manifestations, Pathophysiology, and Management18. Ischemic Demyelination19. Inflammatory Mechanisms in Ischemic Cerebrovascular Disease20. Two-Pore Domain Potassium Channels (K2Ps) as Drug Targets in Neuroinflammation21. Interferon Gamma Versus Beta-Interferon in Pathogenesis of Multiple Sclerosis: Battle of Two Interferons22. Inflammatory Mediators in Obstructive Sleep Apnea23. Central Nervous System Vasculitis24. Role of Inflammatory Mechanisms in Guillain-Barre’ Syndrome25. Roles of Macrophages and Astrocytes in Pathogenesis of Multiple Sclerosis26. Blood-Brain Barrier Disruption During Neuroinflammation 27. Roles of Toll-Like Receptors in Pathophysiology of Alzheimer’s Disease and Multiple Sclerosis28. Role of Neuroinflammation in the Pathophysiology of Traumatic Brain Injury29. The Contribution of Extra Cranial Venous Drainage to Neuro-Inflammation in Multiple Sclerosis30. Lymphatic Drainage of the CNS and Its Role in Neuroinflammation and Neurodegenerative Disease31. A Complete Review on Epigenetic Biomarkers in MS